Related by context. Frequent words. (Click for all words.) 63 Receives CE 60 CryoSeal FS System 60 CE Marking 59 Notified Body 55 ISO Certification 53 CE 52 Investigational Device Exemption 51 Marketing Authorization 51 Mutual Recognition Procedure 50 CE Marked 50 Market Approval PMA 49 FIRAZYR 49 ViroPharma commercializes Vancocin 49 exemption IDE 48 FDA Clearance 48 PMA submission 48 ATryn ® 48 orphan designation 48 k clearance 48 Orphan Drug Designation 48 Orphan Drug designation 48 A2LA 48 FDA approvable letter 47 TAXUS Liberte 47 Phase III pivotal 47 Phase III Clinical Trial 47 ICC ES 47 ISO #:# ISO #:# 47 FDA Accepts 47 CCHIT Certified 47 Orphan Drug status 47 Surgical Ablation System 46 Underwriters Laboratories UL 46 Drug Application 46 k Clearance 46 Humanitarian Device Exemption 46 orphan medicinal product 46 IND submission 46 TyRx 46 GMP certification 46 FDA Orphan Drug 46 Pivotal Phase III 45 UKAS 45 USFDA approval 45 MitraClip R 45 Angiox 45 CORTOSS 45 Plenaxis R 45 Supplemental Type 45 Orphan Drug Status 45 Drug Administration USFDA 45 USFDA 45 Associate Member 45 AS# certification 45 Underwriters Laboratory UL 45 Swissmedic 45 Drug Administration FDA 45 CERTIFICATION 45 received CE Marking 45 Abstral 45 supplemental Biologics License Application 45 Type Approval 45 ISO #:# Certification [002] 45 OTCQX RHHBY 44 Cardiac Resynchronization Therapy 44 Ceftobiprole 44 Application BLA 44 DO #B Level 44 Positive Opinion 44 DC Bead 44 FIPS #-# certification 44 Oracle Validated Integration 44 Common Criteria Certification 44 Conformance 44 ISO TS # 44 Certificate STC 44 Marketing Authorization Application 44 TYRX 44 MONOVISC 43 Rhucin ® 43 UL Certified 43 IEC #-# [002] 43 Drug Eluting Stent 43 GRAS status 43 Ranexa R 43 Regulatory Approval 43 Clinical Trial Application 43 Orphan Medicinal Product 43 Certification 43 Application MAA 43 Marketing Authorization Application MAA 43 ISO #:# Certified 43 TS# [004] 43 Medicinal Products EMEA 43 LVAS 43 MHLW 43 SFDA approval 43 IPv6 Ready 43 ATryn R 43 Test Command JITC 43 Paragraph IV